vs
Side-by-side financial comparison of GUESS INC (GES) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
GUESS INC is the larger business by last-quarter revenue ($791.4M vs $336.6M, roughly 2.4× Guardian Pharmacy Services, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 4.0% vs 3.2%, a 0.8% gap on every dollar of revenue. On growth, GUESS INC posted the faster year-over-year revenue change (7.2% vs 2.2%).
Guess?, Inc. is an American clothing company, notable for its black-and-white advertisements. It licenses its brand on other fashion accessories, such as watches, jewelry, perfumes, bags and shoes.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
GES vs GRDN — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $791.4M | $336.6M |
| Net Profit | $25.6M | $13.5M |
| Gross Margin | 42.5% | 22.7% |
| Operating Margin | 2.9% | 5.3% |
| Net Margin | 3.2% | 4.0% |
| Revenue YoY | 7.2% | 2.2% |
| Net Profit YoY | 209.6% | 46.1% |
| EPS (diluted) | $0.48 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $336.6M | ||
| Q4 25 | $791.4M | $397.6M | ||
| Q3 25 | $772.9M | $377.4M | ||
| Q2 25 | $647.8M | $344.3M | ||
| Q1 25 | $932.3M | $329.3M | ||
| Q4 24 | $738.5M | — | ||
| Q3 24 | $732.6M | $314.4M | ||
| Q2 24 | $591.9M | — |
| Q1 26 | — | $13.5M | ||
| Q4 25 | $25.6M | $20.9M | ||
| Q3 25 | $6.2M | $9.8M | ||
| Q2 25 | $-32.9M | $9.0M | ||
| Q1 25 | $81.4M | $9.4M | ||
| Q4 24 | $-23.4M | — | ||
| Q3 24 | $-10.6M | $-122.0M | ||
| Q2 24 | $13.0M | — |
| Q1 26 | — | 22.7% | ||
| Q4 25 | 42.5% | 21.5% | ||
| Q3 25 | 42.5% | 19.8% | ||
| Q2 25 | 39.9% | 19.8% | ||
| Q1 25 | 44.1% | 19.5% | ||
| Q4 24 | 43.6% | — | ||
| Q3 24 | 43.7% | 19.4% | ||
| Q2 24 | 41.9% | — |
| Q1 26 | — | 5.3% | ||
| Q4 25 | 2.9% | 7.7% | ||
| Q3 25 | 2.3% | 4.3% | ||
| Q2 25 | -5.1% | 3.7% | ||
| Q1 25 | 11.1% | 3.9% | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 6.5% | -33.3% | ||
| Q2 24 | -3.4% | — |
| Q1 26 | — | 4.0% | ||
| Q4 25 | 3.2% | 5.3% | ||
| Q3 25 | 0.8% | 2.6% | ||
| Q2 25 | -5.1% | 2.6% | ||
| Q1 25 | 8.7% | 2.9% | ||
| Q4 24 | -3.2% | — | ||
| Q3 24 | -1.4% | -38.8% | ||
| Q2 24 | 2.2% | — |
| Q1 26 | — | $0.21 | ||
| Q4 25 | $0.48 | — | ||
| Q3 25 | $0.12 | — | ||
| Q2 25 | $-0.65 | — | ||
| Q1 25 | $1.29 | — | ||
| Q4 24 | $-0.47 | — | ||
| Q3 24 | $-0.28 | — | ||
| Q2 24 | $0.23 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $154.2M | $64.9M |
| Total DebtLower is stronger | $299.5M | — |
| Stockholders' EquityBook value | $508.5M | $232.4M |
| Total Assets | $3.0B | $426.9M |
| Debt / EquityLower = less leverage | 0.59× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.9M | ||
| Q4 25 | $154.2M | $65.6M | ||
| Q3 25 | $189.6M | $36.5M | ||
| Q2 25 | $151.2M | $18.8M | ||
| Q1 25 | $187.7M | $14.0M | ||
| Q4 24 | $140.9M | — | ||
| Q3 24 | $218.9M | $37.2M | ||
| Q2 24 | $241.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $299.5M | $0 | ||
| Q3 25 | $258.4M | — | ||
| Q2 25 | $241.7M | — | ||
| Q1 25 | $150.7M | — | ||
| Q4 24 | $238.3M | — | ||
| Q3 24 | $187.8M | $34.3M | ||
| Q2 24 | $196.9M | — |
| Q1 26 | — | $232.4M | ||
| Q4 25 | $508.5M | $217.9M | ||
| Q3 25 | $487.6M | $195.5M | ||
| Q2 25 | $483.6M | $179.7M | ||
| Q1 25 | $505.0M | $163.2M | ||
| Q4 24 | $450.7M | — | ||
| Q3 24 | $491.2M | $133.9M | ||
| Q2 24 | $565.5M | — |
| Q1 26 | — | $426.9M | ||
| Q4 25 | $3.0B | $412.7M | ||
| Q3 25 | $3.0B | $390.0M | ||
| Q2 25 | $2.9B | $356.3M | ||
| Q1 25 | $2.8B | $334.0M | ||
| Q4 24 | $2.8B | — | ||
| Q3 24 | $2.8B | $348.0M | ||
| Q2 24 | $2.7B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.59× | 0.00× | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.38× | 0.26× | ||
| Q2 24 | 0.35× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-39.5M | $6.1M |
| Free Cash FlowOCF − Capex | $-56.3M | — |
| FCF MarginFCF / Revenue | -7.1% | — |
| Capex IntensityCapex / Revenue | 2.1% | — |
| Cash ConversionOCF / Net Profit | -1.54× | 0.45× |
| TTM Free Cash FlowTrailing 4 quarters | $62.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $6.1M | ||
| Q4 25 | $-39.5M | $34.6M | ||
| Q3 25 | $74.9M | $28.2M | ||
| Q2 25 | $-73.4M | $19.9M | ||
| Q1 25 | $183.2M | $17.6M | ||
| Q4 24 | $-83.3M | — | ||
| Q3 24 | $44.7M | — | ||
| Q2 24 | $-22.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-56.3M | — | ||
| Q3 25 | $53.4M | $24.2M | ||
| Q2 25 | $-95.3M | — | ||
| Q1 25 | $160.7M | — | ||
| Q4 24 | $-105.4M | — | ||
| Q3 24 | $24.3M | — | ||
| Q2 24 | $-44.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | -7.1% | — | ||
| Q3 25 | 6.9% | 6.4% | ||
| Q2 25 | -14.7% | — | ||
| Q1 25 | 17.2% | — | ||
| Q4 24 | -14.3% | — | ||
| Q3 24 | 3.3% | — | ||
| Q2 24 | -7.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | — | ||
| Q3 25 | 2.8% | 1.1% | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.6% | — |
| Q1 26 | — | 0.45× | ||
| Q4 25 | -1.54× | 1.65× | ||
| Q3 25 | 12.00× | 2.87× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | 2.25× | 1.86× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GES
| Products | $760.3M | 96% |
| Royalty | $31.1M | 4% |
GRDN
Segment breakdown not available.